Moxalactam pharmacokinetics during hemodialysis

Author:

Aronoff G R,Sloan R S,Mong S A,Luft F C,Kleit S A

Abstract

To establish dosage recommendations, moxalactam elimination kinetics were studied in six anephric patients during hemodialysis and in four anephric patients during the interdialytic period. After a single 1-g intravenous bolus injection, moxalactam elimination half-life was 18.0 plus or minus 0.6 h with a volume of distribution of 20.2 plus or minus 3.6 liters and a plasma clearance of 12.8 plus or minus 2.0 ml/min in four nondialyzed patients. Moxalactam elimination half-life was decreased to 2.7 plus or minus 0.2 h during hemodialysis in six patients. After 4 h, 48.5% of the dose was recovered in the dialysate. The maintenance dose of moxalactam should be decreased to 15% of a normal dose in patients with creatinine clearances less than 10 ml/min, and 50% of a loading dose should be given after hemodialysis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference7 articles.

1. Comparative in vitro activity of 1-oxa-,f-lactam (LY 127935) and cefoperazone with other ,B-lactam antibiotics against anaerobic bacteria;Borborobio M. V.;Antimicrob. Agents Chemother.,1980

2. Brier G. L J. Wolny and J. W. Smith. 1975. Serum bioassay for antimicrobial agents. In Technical improvement service number 21. American Society of Clinical Pathologists Chicago.

3. Artificial kidneys and clearance calculations;Gibson T. P.;Clin. Pharmacol. Ther.,1976

4. Moxalactam (LY 127935), a new semisynthetic 1-oxa-f-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin;Jones R. N.;Antimicrob. Agents Chemother.,1980

5. Clearance calculations in hemodialysis: application to blood, plasma and dialysate measurement for ethambutol;Lee C. S.;J. Pharmacokinet. Biopharm.,1980

Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Removal of Doripenem During Hemodialysis and the Optimum Dosing Regimen for Patients Undergoing Hemodialysis;Therapeutic Apheresis and Dialysis;2011-04-28

2. Single-dose pharmacokinetics of cefpirome in patients with renal impairment;Clinical Pharmacology and Therapeutics;1992-07

3. Clinical Pharmacokinetics of Antibiotics in Patients with Impaired Renal Function;Clinical Pharmacokinetics;1992-03

4. L;Drug Dosage in Renal Insufficiency;1991

5. Pharmacological Considerations for Renal Failure and Dialysis;Replacement of Renal Function by Dialysis;1989

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3